v字仇杀队

China's first domestically built large cruise ship launches GBA international route_我的网站

一 |     (ECNS) -- Adora Magic City, China’s first domestically built large cruise ship, set sail from Shekou Cruise Homeport in Shenzhen, Guangdong Province, on Thursday, bound for Vietnam.    Shenzhen marked the departure with a traditional water salute ceremony.        The voyage marks Adora Magic City’s first international cruise route departing from the Guangdong-Hong Kong-Macao Greater Bay Area (GBA).    Carrying nearly 4,600 passengers, the cruise ship will call at Chan May Port in Hue, Vietnam, during the five-day, four-night voyage.    Its Shenzhen-based cruise season will run through September 16, offering five-day, four-night and six-day, five-night itineraries to Chan May Port in Hue, Ha Long Bay and Cam Ranh Port in Nha Trang, Vietnam, as well as Jeju in the Republic of Korea.    A special nine-day, eight-night voyage will depart on August 27, calling at Kota Kinabalu in Malaysia, Muara in Brunei and Nha Trang in Vietnam along the ancient Maritime Silk Road.    China’s second domestically built large cruise ship, Adora Flora City, is scheduled for delivery on November 6 this year and will embark on its maiden voyage from Guangzhou Nansha International Cruise Homeport in Guangdong Province on Nov. 22.    (By Helen Mo, intern Xu Wenda)                    。    近日，杭州医药港传来消息：天境生物研发的注射用菲泽妥单抗（商品名：境斐^[®]），拿到了国家药品监督管理局的上市批准。

二 | 这款药将联合来那度胺和地塞米松，用于治疗既往至少接受过一线治疗的多发性骨髓瘤成年患者。这是该产品在全球范围内的首次获批。境斐^[®]是一款靶向CD38的人源单克隆抗体，整个多发性骨髓瘤适应证的临床开发和注册申报，全部由天境生物在中国完成。“10年前，这些药要等在国外上市了，再引进到中国重新做开发。现在反过来了。”天境生物董事长钱丽丽说。

三 | 境斐^[®]的获批，让钱塘区今年上市的1类创新药增至3款，数量位列全省第一。

四 | 截至目前，杭州医药港已集聚生物医药企业1800多家，累计4款1类创新药获批上市。另有138个创新药进入临床试验，数量居杭州市首位，其中14个药品已处于临床三期。

Current article:http://93jw0g9.chuandanfozhuanbenglipaicuzi.pics/news/20260826_654936.html

Published on:10:59:20